Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetonal versus meloxicam for pain relief and functional improvement in knee osteoarthritis
IRCT20191031045291N1Phase 4Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of meloxicam in knee osteoarthritis (OA) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Pain relief and Functional improvement. Started Dec 2019; status: completed.
02
Drugs
meloxicam
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20191031045291N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191031045291N1.